CMS released the Calendar Year 2027 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Proposed Rule on July 2, 2026, with Federal Register publication following on July 7. Comments are due August 31, 2026. While OPPS is nominally a hospital rule, four provisions land squarely on physician practices and the ASCs they operate in.
The rule also carries a Request for Information on strengthening hospital price transparency data — CMS is explicitly asking how to improve comparability and standardization of machine-readable files, particularly for complex contracting methodologies. This RFI is the clearest signal yet that enforcement will tighten around data quality, not just file existence.
The CY 2027 Physician Fee Schedule proposed rule is expected mid-July — CMS has released it in mid-July in each of the past several cycles. Two things to watch: the one-time 2.5% payment increase Congress provided for 2026 expires at year-end, meaning the 2027 baseline starts with a cut unless Congress acts; and 2027 is year one of the Ambulatory Specialty Model — the first mandatory, specialist-level accountability model in traditional Medicare (details in Section 09).
Comments on the CY 2027 OPPS/ASC proposed rule are due August 31, 2026 — the same day as the OBBBA Medicaid enrollee-outreach deadline. Practices with ASC ownership or hospital-outpatient billing should have their comment letters and their Medicaid outreach plans on the same August calendar.
Roughly one year after some 50 insurers pledged to simplify and reduce prior authorization across commercial, Medicare Advantage, and managed Medicaid plans covering 257 million Americans, the first hard progress numbers are in: participating insurers have collectively eliminated 11% of PA requirements, translating to approximately 6.5 million fewer prior authorization requests.
| Payer | Standardization / Reduction Progress | What It Means for Your Practice |
|---|---|---|
| Aetna | 88% of PA volume standardized; claims the fewest medical services requiring PA among national plans | Fastest turnarounds on standardized categories; verify which of your top-20 codes still require PA |
| UnitedHealthcare | Committed to ≥70% standardization; eliminated 20% of PAs in 2023; additional 30% reduction announced in May covering outpatient surgeries, diagnostics, therapies, chiropractic — completing by year-end | Re-check UHC PA requirements quarterly; codes are dropping off the list mid-year |
| Cigna | Committed to standardizing >70% of medical PA volume by end of 2026 | Standardized submission templates will reduce per-PA handling time once live |
| UHC (rural) | PA exemptions extended to ~1,500 rural hospitals and critical access facilities in April | Rural-affiliated practices should confirm exemption status in writing |
The July 2026 UHC policy bulletin adds routine but consequential updates: MassHealth-driven removal of weight-loss and obesity drug coverage in Massachusetts Medicaid effective July 3, Individual Exchange Plan drug list additions effective July 1, and network additions. If your denial-management system routes by payer policy version, July’s bulletin needs to be loaded now.
NewYork-Presbyterian and UnitedHealthcare agreed to extend in-network coverage for most commercial plan members through July 31, 2026 while negotiations continue. (The Medicare Advantage exit proceeded July 1 as covered in last week’s issue.) Practices in the NYP referral orbit now face a two-track network status: MA patients out-of-network since July 1, commercial patients in-network only through month-end unless a deal lands.
The countervailing force: while payers tout PA reduction, the CY 2027 OPPS proposed rule (Section 01) expands PA in hospital outpatient settings, and the WISeR model (Section 07) applies AI-assisted review to selected services in six states. The net PA trajectory for practices is not “less PA” — it is PA migrating from volume to targeting.
6.5 million fewer PA requests in year one of the AHIP pledge — but with denial rates still elevated and PA expanding in targeted categories, the average practice’s PA staff burden has fallen far less than the headline suggests. MGMA’s most recent data still puts PA at nearly 15 staff-hours per physician per week.
A July 7, 2026 Healthcare IT Today community roundup crystallized the emerging consensus in RCM automation: even as AI takes over upstream work at scale, clinical denials and appeals still require human judgment — because they combine medical necessity, payer policy interpretation, coding standards, and physician-documentation nuance in ways current AI cannot reliably navigate alone.
The winning pattern is automation throughput with reviewer accountability: AI handles volume; humans own exceptions, appeals, and anything requiring clinical interpretation — with audit trails and escalation workflows built in from day one. Organizations that removed human review from clinical denial workflows are quietly adding it back after appeal overturn rates dropped.
The question practices should ask vendors is no longer “what can your AI automate?” — it is “where does your system hand off to a human, and how is that handoff audited?” Vendors without a crisp answer are selling you tomorrow’s rework queue.
With FY 2027 ICD-10-CM codes effective October 1, 2026, July is the right month for a mid-year audit of the FY 2026 guideline changes that continue to generate preventable denials and audit exposure nine months after taking effect.
The 2026 CPT set expanded billable digital health and AI-supported services — AI-assisted diagnostics, remote monitoring, and digital therapeutics now have dedicated codes, meaning services previously bundled under broader E/M codes may warrant standalone reporting. Practices that built their charge capture before January 2026 and haven’t revisited it are leaving newly billable services inside bundled codes.
Run a focused audit of H1 2026 claims for the four trap patterns above. Each is mechanically checkable: B20 claims without HIV-disease documentation, active diabetes codes on patients with “remission” in the note, standalone BMI Z-codes, and multiple-site codes on notes naming specific sites. Fix the encoder logic and coder guidance now — FY 2027 code training starts in August and you don’t want to carry FY 2026 errors into it.
Denials have graduated from operational nuisance to boardroom line item. In the latest industry surveys, 36% of RCM leaders say denial impact is now discussed at the executive level of their organization — and the labor numbers explain why: most RCM teams report spending 51 to 75 hours every week on denial-related work. That is 1.3 to 1.9 FTEs doing nothing but arguing with payers.
| Metric | Industry Benchmark | Top Performer | Warning Threshold |
|---|---|---|---|
| Clean Claim Rate (first pass) | 95%+ | 98–99% | Below 90% |
| Days in A/R | 30–40 days | Under 25 days | Over 45 days |
| Weekly denial-work hours | 51–75 hrs (typical) | Under 25 hrs with automation | Over 75 hrs |
The velocity connection: practices with clean claim rates above 95% consistently hold Days in A/R below 35. The compounding rule of thumb from 2026 benchmark data: a 5-percentage-point improvement in first-pass acceptance typically removes 5–10 days from A/R. Denial prevention is not just a write-off play — it is the single fastest lever on cash velocity.
If your team is inside the 51–75 hour band, the arithmetic is stark: at a loaded cost of $35/hour, denial labor costs $93,000–$137,000 per year before counting a single written-off dollar. A denial-prevention program that cuts the queue by a third pays for itself on labor alone — the recovered revenue is upside.
The RCM vendor market opened H2 2026 with another consolidation move: Experity announced July 1 that it acquired Exdion Healthcare, an AI-driven SaaS company specializing in coding, billing, compliance, and revenue cycle automation. The deal advances Experity’s strategy of unifying clinical, operational, and financial workflows under one AI-native platform — with on-demand/urgent care as the beachhead.
| Acquirer | Target | Price | Strategic Logic |
|---|---|---|---|
| Experity | Exdion Healthcare | Undisclosed (July 1, 2026) | AI coding + billing automation into urgent-care platform |
| Waystar | Iodine Software | $1.25B | AI clinical documentation integrity embedded in claims workflow |
Why vendors are consolidating: the RCM AI market is projected to grow from $8.4 billion (2025) to $33.6 billion (2034) — but with 120+ point solutions in the market, integration complexity has become the primary constraint on customer ROI. Platforms are buying point solutions because the buyers of RCM technology increasingly refuse to stitch tools together themselves.
Vendor consolidation is accelerating precisely because integration is where RCM value is created or destroyed. If your stack has more than three RCM vendors with manual handoffs between them, you are holding integration risk that the market is actively pricing out — evaluate platform consolidation before your vendors force the timing on you.
The long-awaited HIPAA Security Rule overhaul has slipped again: OCR’s regulatory agenda had targeted May 2026 for finalization, but the month passed with no rule — and the OMB website now shows final action pushed to July 2027. Practices tempted to relax should read the enforcement record first: OCR is actively enforcing the existing Security Rule right now, and the enforcement themes preview exactly what the final rule will demand.
Separately from HIPAA, CMS’s Wasteful and Inappropriate Service Reduction (WISeR) model has been running since January 15, 2026 in six states — New Jersey, Ohio, Oklahoma, Texas, Arizona, and Washington — applying AI-assisted review to selected services in traditional Medicare. Practices in those states should treat WISeR-covered services with PA-level documentation discipline even though traditional Medicare historically required none.
| Deadline | Event | Action Required |
|---|---|---|
| July 31, 2026 | NYP/UHC commercial network extension expires | Track negotiation outcome; identify affected commercial patients |
| August 31, 2026 | CY 2027 OPPS/ASC comment deadline | Submit comments on PA expansion, site-neutral, 340B provisions |
| August 31, 2026 | OBBBA enrollee outreach deadline | Staff training complete; patient education materials ready |
| September 30, 2026 | Pre-ICD-10 encoder update deadline | All encoder/EHR systems updated for FY 2027 codes |
| October 1, 2026 | ICD-10-CM/PCS FY 2027 codes effective | Coder training complete; first-day claims use new codes |
| Q4 2026 | CMS-0062-P Drug PA Final Rule expected | Vendor readiness assessment |
| January 1, 2027 | CMS-0057-F FHIR PA API mandatory; ASM year one begins | Verify clearinghouse API status; confirm ASM roster status (Section 09) |
MGMA’s mid-year polling paints the clearest picture yet of the 2026 independent-practice margin squeeze — and of the operational levers separating the practices that are absorbing it from the ones being consolidated by it.
Doctor-owned super-groups and independent MSO structures are emerging as credible alternatives to hospital employment and PE acquisition — specialty-driven networks that let independents pool contracting leverage, purchasing power, and technology spend without surrendering ownership. For practices facing the squeeze, the strategic menu is no longer just “sell or suffer.”
With 84% of groups facing higher costs and reimbursement flat-to-down (the 2026 PFS’s 2.5% boost expires December 31 — Section 01), the revenue-cycle gap between median and top-quartile performance is worth more than any plausible payer rate negotiation. A practice collecting at the median (91–93% NCR, 40+ days in A/R) that reaches top-quartile performance (96%+ NCR, sub-30 A/R) recovers 3–5 points of net revenue — without a single new patient.
| Benchmark | Where Most Are | Where You Should Be |
|---|---|---|
| Net Collection Rate | 91–93% | > 96% |
| Days in A/R | 38–45 days | < 30 days |
| Clean Claim Rate (first pass) | 91–93% | > 95% (top: 98%+) |
| Denial Rate | 8–12% | < 5% |
| Weekly denial-work hours | 51–75 hrs | < 25 hrs (with automation) |
| Cost to Collect | 6–8% | < 4% |
Run the five-number squeeze test on your own practice this week: YTD cost growth vs. 2025, YTD revenue growth vs. 2025, NCR, days in A/R, and weekly denial hours. If costs are growing faster than revenue AND you are below benchmark on two or more RCM metrics, the gap is operational — and closable — before it becomes existential.
| Specialty | Key Update | Revenue / Billing Impact |
|---|---|---|
| Cardiology | The mandatory Ambulatory Specialty Model (ASM) begins January 1, 2027 for heart failure care — 6,600+ clinicians mandated across roughly a quarter of U.S. metro areas, two-sided risk starting at ±9% of Part B revenue and scaling to ±12%. Critical: hundreds of cardiologists were incorrectly added to the participant roster in CMS’s initial selection files. Separately, cardiology faces an estimated $700M Medicare reimbursement loss from 2026 payment cuts. | Check your NPI against the ASM participant list now. If you are listed erroneously (wrong specialty, insufficient episode volume), the correction window is before the performance year starts — not after. If correctly included, 2027 performance drives 2029 payment: MIPS-style scoring across Quality, Cost, Improvement Activities, and Interoperability begins in six months. |
| Primary Care | The 2026 PFS delivered a 10% increase in CCM reimbursement — one of the largest in program history — plus new APCM behavioral health add-on codes (G0568, G0569, G0570) mirroring BHI/CoCM structures. RPM, CCM, and BHI remain concurrently billable when documentation and time requirements are met independently. | Verify your fee schedule loaded the 2026 CCM rates — practices billing at 2025 rates through H1 have underbilled roughly 10% on every CCM claim. Model the APCM add-on stack: for a 200-patient CCM panel with behavioral health integration, the add-ons represent a five-figure annual revenue line. |
| Orthopedics | Low-back-pain specialists (orthopedic surgery, pain management, PM&R, neurosurgery) are the second mandatory ASM cohort for January 2027 — same roster-error caveat as cardiology. Orthopedic procedures in the six WISeR states (NJ, OH, OK, TX, AZ, WA) face AI-assisted review in traditional Medicare since January 15. | Check ASM roster status for every spine/pain clinician in the group. In WISeR states, apply PA-grade documentation to covered ortho services in traditional Medicare — the historic “no PA in Medicare” assumption no longer holds. |
| Oncology | The CY 2027 OPPS proposed rule restructures Medicare payment for 340B-acquired drugs and accelerates the 340B remedy budget-neutrality adjustment. The CMS-0062-P drug PA final rule (24-hour urgent decisions) is expected Q4 2026. | Oncology practices affiliated with 340B covered entities should model infusion-margin impact under the proposed restructuring and file comments by August 31. The 24-hour urgent drug PA window, once final, materially reduces chemo start delays — build the expedited-request workflow template now. |
| Mental Health | The APCM behavioral health add-ons (G0568–G0570) create a new integration revenue path with primary care. Psychotherapy time-documentation enforcement continues: 90832/90834/90837 must each meet required minimum minutes. | For practices in collaborative care arrangements, the add-on codes monetize integration work previously absorbed as overhead. Continue H1 time-documentation audits — minimum-minute failures remain a top MH denial and clawback trigger. |
The ASM roster errors are the sleeper RCM issue of the summer. A cardiologist or spine surgeon incorrectly enrolled in a mandatory two-sided risk model faces payment adjustments on all Part B revenue based on a scoring framework they never should have entered. Verification takes an hour; discovering the error in 2029 — when the payment adjustment hits — is unrecoverable.